Pages that link to "Q75026031"
Jump to navigation
Jump to search
The following pages link to Jennifer Le-Rademacher (Q75026031):
Displaying 29 items.
- Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome (Q30371042) (← links)
- Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? (Q30414156) (← links)
- Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia (Q30415126) (← links)
- Salvage second hematopoietic cell transplantation in myeloma (Q30416452) (← links)
- Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO. (Q31109949) (← links)
- Methods for generating paired competing risks data (Q31126215) (← links)
- Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission (Q33900803) (← links)
- Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. (Q34175457) (← links)
- Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood (Q34217884) (← links)
- Hematopoietic stem cell transplantation for infantile osteopetrosis (Q34477968) (← links)
- Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation (Q34649014) (← links)
- Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia (Q35197402) (← links)
- Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure (Q36055113) (← links)
- Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? (Q36410168) (← links)
- Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902) (Q36447635) (← links)
- Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes (Q37021454) (← links)
- Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR (Q37490480) (← links)
- Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials (Q38716340) (← links)
- Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial (Q38827434) (← links)
- Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes (Q38852431) (← links)
- Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). (Q39289941) (← links)
- Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis (Q39518931) (← links)
- Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial (Q40702849) (← links)
- Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies (Q42175192) (← links)
- Weighted comparison of two cumulative incidence functions with R-CIFsmry package (Q42725835) (← links)
- Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. (Q50716088) (← links)
- Olanzapine versus fosaprepitant for the prevention of concurrent chemotherapy radiotherapy-induced nausea and vomiting. (Q54020641) (← links)
- Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations (Q57161373) (← links)
- Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells (Q64073868) (← links)